237 related articles for article (PubMed ID: 30457899)
1. Quantitative assessment of intravenous regional limb perfusion of tiludronate as an adjunctive treatment for lameness caused by navicular syndrome in horses.
Schoonover MJ; Whitfield CT; Young JM; Sippel KM; Payton ME
Am J Vet Res; 2018 Dec; 79(12):1313-1320. PubMed ID: 30457899
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of two methods of tiludronate administration for the treatment of lameness caused by navicular syndrome in horses.
Whitfield CT; Schoonover MJ; Holbrook TC; Payton ME; Sippel KM
Am J Vet Res; 2016 Feb; 77(2):167-73. PubMed ID: 27027711
[TBL] [Abstract][Full Text] [Related]
3. Quantitative comparison of three commonly used treatments for navicular syndrome in horses.
Schoonover MJ; Jann HW; Blaik MA
Am J Vet Res; 2005 Jul; 66(7):1247-51. PubMed ID: 16111165
[TBL] [Abstract][Full Text] [Related]
4. Tiludronate infusion in the treatment of bone spavin: a double blind placebo-controlled trial.
Gough MR; Thibaud D; Smith RK
Equine Vet J; 2010 Jul; 42(5):381-7. PubMed ID: 20636772
[TBL] [Abstract][Full Text] [Related]
5. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
Erkert RS; MacAllister CG; Payton ME; Clarke CR
Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129
[TBL] [Abstract][Full Text] [Related]
6. Injection of corticosteroids, hyaluronate, and amikacin into the navicular bursa in horses with signs of navicular area pain unresponsive to other treatments: 25 cases (1999-2002).
Dabareiner RM; Carter GK; Honnas CM
J Am Vet Med Assoc; 2003 Nov; 223(10):1469-74. PubMed ID: 14627099
[TBL] [Abstract][Full Text] [Related]
7. Tiludronate concentrations and cytologic findings in synovial fluid after intravenous regional limb perfusion with tiludronate in horses.
Hunter BG; Duesterdieck-Zellmer KF; Larson MK
PeerJ; 2015; 3():e889. PubMed ID: 25945303
[TBL] [Abstract][Full Text] [Related]
8. Tiludronate as a new therapeutic agent in the treatment of navicular disease: a double-blind placebo-controlled clinical trial.
Denoix JM; Thibaud D; Riccio B
Equine Vet J; 2003 Jun; 35(4):407-13. PubMed ID: 12880010
[TBL] [Abstract][Full Text] [Related]
9. The effects of local anaesthetic solution in the navicular bursa of horses with lameness caused by distal interphalangeal joint pain.
Schumacher J; Schumacher J; Gillette R; DeGraves F; Schramme M; Smith R; Perkins J; Coker M
Equine Vet J; 2003 Jul; 35(5):502-5. PubMed ID: 12875330
[TBL] [Abstract][Full Text] [Related]
10. Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial.
Richbourg HA; Mitchell CF; Gillett AN; McNulty MA
BMC Vet Res; 2018 Mar; 14(1):105. PubMed ID: 29554967
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of clodronic acid in horses diagnosed with navicular syndrome: A field study using objective and subjective lameness evaluation.
Argüelles D; Saitua A; de Medina AS; Muñoz JA; Muñoz A
Res Vet Sci; 2019 Aug; 125():298-304. PubMed ID: 31351199
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of podotrochlear (navicular) bursa injections for signs of foot pain in horses evaluated via magnetic resonance imaging: 23 cases (2005-2007).
Bell CD; Howard RD; Taylor DS; Voss ED; Werpy NM
J Am Vet Med Assoc; 2009 Apr; 234(7):920-5. PubMed ID: 19335243
[TBL] [Abstract][Full Text] [Related]
13. Histopathology in horses with chronic palmar foot pain and age-matched controls. Part 1: Navicular bone and related structures.
Blunden A; Dyson S; Murray R; Schramme M
Equine Vet J; 2006 Jan; 38(1):15-22. PubMed ID: 16411581
[TBL] [Abstract][Full Text] [Related]
14. Oral treatment with a nutraceutical (Cosequin) for ameliorating signs of navicular syndrome in horses.
Hanson RR; Brawner WR; Blaik MA; Hammad TA; Kincaid SA; Pugh DG
Vet Ther; 2001; 2(2):148-59. PubMed ID: 19753708
[TBL] [Abstract][Full Text] [Related]
15. The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.
Back W; MacAllister CG; van Heel MC; Pollmeier M; Hanson PD
Equine Vet J; 2009 Mar; 41(3):309-12. PubMed ID: 19469242
[TBL] [Abstract][Full Text] [Related]
16. Effects of intrabursal administration of botulinum toxin type B on lameness in horses with degenerative injury to the podotrochlear apparatus.
Gutierrez-Nibeyro SD; Santos MP; White NA; Brown JA; Adams MN; McKnight AL; Schaeffer DJ
Am J Vet Res; 2014 Mar; 75(3):282-9. PubMed ID: 24564314
[TBL] [Abstract][Full Text] [Related]
17. Objective evaluation for analgesia of the distal interphalangeal joint, the navicular bursa and perineural analgesia in horses with naturally occurring forelimb lameness localised to the foot.
Katrinaki V; Estrada RJ; Mählmann K; Kolokythas P; Lischer CJ
Equine Vet J; 2023 Mar; 55(2):253-260. PubMed ID: 35488427
[TBL] [Abstract][Full Text] [Related]
18. Distal border fragments of the equine navicular bone: association between magnetic resonance imaging characteristics and clinical lameness.
Yorke EH; Judy CE; Saveraid TC; McGowan CP; Caldwell FJ
Vet Radiol Ultrasound; 2014; 55(1):35-44. PubMed ID: 23890103
[TBL] [Abstract][Full Text] [Related]
19. Intra-articular anesthesia of the distal interphalangeal joint alleviates lameness associated with the navicular bursa in horses.
Pleasant RS; Moll HD; Ley WB; Lessard P; Warnick LD
Vet Surg; 1997; 26(2):137-40. PubMed ID: 9068164
[TBL] [Abstract][Full Text] [Related]
20. Effects of analgesia of the digital flexor tendon sheath on pain originating in the sole, distal interphalangeal joint or navicular bursa of horses.
Harper J; Schumacher J; Degraves F; Schramme M; Schumacher J
Equine Vet J; 2007 Nov; 39(6):535-9. PubMed ID: 18065312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
